Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction - CNBC

Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer's drug, Leqembi, … [+1992 chars]